Obesity as a Disease

  • Jagriti Upadhyay
    Correspondence
    Corresponding author. Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Stoneman 820, Boston, MA 02215.
    Affiliations
    Section of Endocrinology, Diabetes and Metabolism, Boston VA Healthcare System, 150 South Huntington Avenue, Boston, MA 02130, USA

    Division of Endocrinology, Boston Medical Center, Boston University, 88 East Newton Street, Boston, MA 02118

    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Search for articles by this author
  • Olivia Farr
    Affiliations
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Search for articles by this author
  • Nikolaos Perakakis
    Affiliations
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Search for articles by this author
  • Wael Ghaly
    Affiliations
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Search for articles by this author
  • Christos Mantzoros
    Affiliations
    Section of Endocrinology, Diabetes and Metabolism, Boston VA Healthcare System, 150 South Huntington Avenue, Boston, MA 02130, USA

    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Search for articles by this author
Published:October 21, 2017DOI:https://doi.org/10.1016/j.mcna.2017.08.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Medical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hu F.B.
        Obesity and mortality: watch your waist, not just your weight.
        Arch Intern Med. 2007; 167: 875-876
        • Hedley A.A.
        • Ogden C.L.
        • Johnson C.L.
        • et al.
        Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
        JAMA. 2004; 291: 2847-2850
        • Kahan S.
        • Zvenyach T.
        Obesity as a disease: current policies and implications for the future.
        Curr Obes Rep. 2016; 5: 291-297
        • Bray G.A.
        • Kim K.K.
        • Wilding J.P.H.
        Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.
        Obes Rev. 2017; 18: 715-723
        • Baskin M.L.
        • Ard J.
        • Franklin F.
        • et al.
        Prevalence of obesity in the United States.
        Obes Rev. 2005; 6: 5-7
        • Whitlock G.
        • Lewington S.
        • Sherliker P.
        • et al.
        Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
        Lancet. 2009; 373: 1083-1096
        • Cawley J.
        • Meyerhoefer C.
        The medical care costs of obesity: an instrumental variables approach.
        J Health Econ. 2012; 31: 219-230
        • Church T.S.
        • Thomas D.M.
        • Tudor-Locke C.
        • et al.
        Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity.
        PLoS One. 2011; 6: e19657
        • Popkin B.M.
        • Hawkes C.
        Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses.
        Lancet Diabetes Endocrinol. 2016; 4: 174-186
        • Njike V.Y.
        • Smith T.M.
        • Shuval O.
        • et al.
        Snack food, satiety, and weight.
        Adv Nutr. 2016; 7: 866-878
        • Medici V.
        • McClave S.A.
        • Miller K.R.
        Common medications which lead to unintended alterations in weight gain or organ lipotoxicity.
        Curr Gastroenterol Rep. 2016; 18: 2
        • Cooke L.
        • Llewellyn C.
        Nature and nurture in early feeding behavior.
        Nestle Nutr Inst Workshop Ser. 2016; 85: 155-165
        • Bray M.S.
        • Loos R.J.
        • McCaffery J.M.
        • et al.
        NIH working group report-using genomic information to guide weight management: From universal to precision treatment.
        Obesity (Silver Spring). 2016; 24: 14-22
        • Bjornland T.
        • Langaas M.
        • Grill V.
        • et al.
        Assessing gene-environment interaction effects of FTO, MC4R and lifestyle factors on obesity using an extreme phenotype sampling design: results from the HUNT study.
        PLoS One. 2017; 12: e0175071
        • Albuquerque D.
        • Stice E.
        • Rodriguez-Lopez R.
        • et al.
        Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective.
        Mol Genet Genomics. 2015; 290: 1191-1221
        • Farooqi I.S.
        • Matarese G.
        • Lord G.M.
        • et al.
        Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.
        J Clin Invest. 2002; 110: 1093-1103
        • Ho G.
        • MacKenzie R.G.
        Functional characterization of mutations in melanocortin-4 receptor associated with human obesity.
        J Biol Chem. 1999; 274: 35816-35822
        • Farooqi I.S.
        • O'Rahilly S.
        Monogenic obesity in humans.
        Annu Rev Med. 2005; 56: 443-458
        • Ronn T.
        • Volkov P.
        • Davegardh C.
        • et al.
        A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue.
        PLoS Genet. 2013; 9: e1003572
        • Widiker S.
        • Karst S.
        • Wagener A.
        • et al.
        High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines.
        J Appl Genet. 2010; 51: 193-197
        • Almen M.S.
        • Jacobsson J.A.
        • Moschonis G.
        • et al.
        Genome wide analysis reveals association of a FTO gene variant with epigenetic changes.
        Genomics. 2012; 99: 132-137
        • Farr O.M.
        • Li C.S.
        • Mantzoros C.S.
        Central nervous system regulation of eating: insights from human brain imaging.
        Metabolism. 2016; 65: 699-713
        • Farr O.M.
        • Gavrieli A.
        • Mantzoros C.S.
        Leptin applications in 2015: what have we learned about leptin and obesity?.
        Curr Opin Endocrinol Diabetes Obes. 2015; 22: 353-359
        • Farr O.M.
        • Tsoukas M.A.
        • Mantzoros C.S.
        Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders.
        Metabolism. 2015; 64: 114-130
        • Stieg M.R.
        • Sievers C.
        • Farr O.
        • et al.
        Leptin: a hormone linking activation of neuroendocrine axes with neuropathology.
        Psychoneuroendocrinology. 2015; 51: 47-57
        • Balland E.
        • Cowley M.A.
        New insights in leptin resistance mechanisms in mice.
        Front Neuroendocrinol. 2015; 39: 59-65
        • Crujeiras A.B.
        • Carreira M.C.
        • Cabia B.
        • et al.
        Leptin resistance in obesity: an epigenetic landscape.
        Life Sci. 2015; 140: 57-63
        • Sainz N.
        • Barrenetxe J.
        • Moreno-Aliaga M.J.
        • et al.
        Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.
        Metabolism. 2015; 64: 35-46
        • Farr O.M.
        • Sofopoulos M.
        • Tsoukas M.A.
        • et al.
        GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial.
        Diabetologia. 2016; 65: 2943-2953
        • Farr O.M.
        • Tsoukas M.A.
        • Triantafyllou G.
        • et al.
        Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study.
        Metabolism. 2016; 65: 945-953
        • Baik J.H.
        Dopamine signaling in food addiction: role of dopamine D2 receptors.
        BMB Rep. 2013; 46: 519-526
        • Blum K.
        • Thanos P.K.
        • Gold M.S.
        Dopamine and glucose, obesity, and reward deficiency syndrome.
        Front Psychol. 2014; 5: 919
        • Burger K.S.
        • Stice E.
        Variability in reward responsivity and obesity: evidence from brain imaging studies.
        Curr Drug Abuse Rev. 2011; 4: 182-189
        • DiLeone R.J.
        • Taylor J.R.
        • Picciotto M.R.
        The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction.
        Nat Neurosci. 2012; 15: 1330-1335
        • Figlewicz D.P.
        Adiposity signals and food reward: expanding the CNS roles of insulin and leptin.
        Am J Physiol Regul Integr Comp Physiol. 2003; 284: R882-R892
        • Garcia-Garcia I.
        • Horstmann A.
        • Jurado M.A.
        • et al.
        Reward processing in obesity, substance addiction and non-substance addiction.
        Obes Rev. 2014; 15: 853-869
        • Gosnell B.A.
        • Levine A.S.
        Reward systems and food intake: role of opioids.
        Int J Obes (Lond). 2009; 33: S54-S58
        • Kelley M.
        • Khan N.A.
        • Rolls E.T.
        Taste, olfactory, and food reward value processing in the brain.
        Adv Nutr. 2015; 127-128: 64-90
        • King B.M.
        The modern obesity epidemic, ancestral hunter-gatherers, and the sensory/reward control of food intake.
        Am Psychol. 2013; 68: 88-96
        • Michaelides M.
        • Thanos P.K.
        • Volkow N.D.
        • et al.
        Translational neuroimaging in drug addiction and obesity.
        ILAR J. 2012; 53: 59-68
        • Murray S.
        • Tulloch A.
        • Gold M.S.
        • et al.
        Hormonal and neural mechanisms of food reward, eating behaviour and obesity.
        Nat Rev Endocrinol. 2014; 10: 540-552
        • Small D.M.
        Individual differences in the neurophysiology of reward and the obesity epidemic.
        Int J Obes (Lond). 2009; 33: S44-S48
        • Smith D.G.
        • Robbins T.W.
        The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction model.
        Biol Psychiatry. 2013; 73: 804-810
        • Stice E.
        • Figlewicz D.P.
        • Gosnell B.A.
        • et al.
        The contribution of brain reward circuits to the obesity epidemic.
        Neurosci Biobehav Rev. 2013; 37: 2047-2058
        • Volkow N.D.
        • Wang G.J.
        • Fowler J.S.
        • et al.
        Food and drug reward: overlapping circuits in human obesity and addiction.
        Curr Top Behav Neurosci. 2012; 11: 1-24
        • Volkow N.D.
        • Wang G.J.
        • Tomasi D.
        • et al.
        The addictive dimensionality of obesity.
        Biol Psychiatry. 2013; 73: 811-818
        • Volkow N.D.
        • Wang G.J.
        • Tomasi D.
        • et al.
        Obesity and addiction: neurobiological overlaps.
        Obes Rev. 2013; 14: 2-18
        • Wang G.J.
        • Volkow N.D.
        • Fowler J.S.
        The role of dopamine in motivation for food in humans: implications for obesity.
        Expert Opin Ther Targets. 2002; 6: 601-609
        • Wang G.J.
        • Volkow N.D.
        • Thanos P.K.
        • et al.
        Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.
        J Addict Dis. 2004; 23: 39-53
        • Wise R.A.
        Dual roles of dopamine in food and drug seeking: the drive-reward paradox.
        Biol Psychiatry. 2013; 73: 819-826
        • Ziauddeen H.
        • Alonso-Alonso M.
        • Hill J.O.
        Obesity and the neurocognitive basis of food reward and the control of intake.
        Adv Nutr. 2015; 6: 474-486
        • Dunn J.P.
        • Kessler R.M.
        • Feurer I.D.
        • et al.
        Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity.
        Diabetes Care. 2012; 35: 1105-1111
        • Thanos P.K.
        • Michaelides M.
        • Piyis Y.K.
        • et al.
        Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography.
        Synapse. 2008; 62: 50-61
        • Dunn J.P.
        • Cowan R.L.
        • Volkow N.D.
        • et al.
        Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings.
        Brain Res. 2010; 1350: 123-130
        • Volkow N.D.
        • Wang G.J.
        • Telang F.
        • et al.
        Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.
        Neuroimage. 2008; 42: 1537-1543
        • Wang G.J.
        • Volkow N.D.
        • Logan J.
        • et al.
        Brain dopamine and obesity.
        Lancet. 2001; 357: 354-357
        • Rothemund Y.
        • Preuschhof C.
        • Bohner G.
        • et al.
        Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals.
        Neuroimage. 2007; 37: 410-421
        • Stice E.
        • Yokum S.
        • Bohon C.
        • et al.
        Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4.
        Neuroimage. 2010; 50: 1618-1625
        • Beaver J.D.
        • Lawrence A.D.
        • van Ditzhuijzen J.
        • et al.
        Individual differences in reward drive predict neural responses to images of food.
        J Neurosci. 2006; 26: 5160-5166
        • Pelchat M.L.
        • Johnson A.
        • Chan R.
        • et al.
        Images of desire: food-craving activation during fMRI.
        Neuroimage. 2004; 23: 1486-1493
        • Yokum S.
        • Ng J.
        • Stice E.
        Attentional bias to food images associated with elevated weight and future weight gain: an fMRI study.
        Obesity (Silver Spring). 2011; 19: 1775-1783
        • Dong C.
        • Sanchez L.E.
        • Price R.A.
        Relationship of obesity to depression: a family-based study.
        Int J Obes Relat Metab Disord. 2004; 28: 790-795
        • Novick J.S.
        • Stewart J.W.
        • Wisniewski S.R.
        • et al.
        Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.
        J Clin Psychiatry. 2005; 66: 1002-1011
        • Potenza M.N.
        Obesity, food, and addiction: emerging neuroscience and clinical and public health implications.
        Neuropsychopharmacology. 2014; 39: 249-250
        • Roberts R.E.
        • Deleger S.
        • Strawbridge W.J.
        • et al.
        Prospective association between obesity and depression: evidence from the Alameda County Study.
        Int J Obes Relat Metab Disord. 2003; 27: 514-521
        • Simon G.E.
        • Von Korff M.
        • Saunders K.
        • et al.
        Association between obesity and psychiatric disorders in the US adult population.
        Arch Gen Psychiatry. 2006; 63: 824-830
        • Farr O.M.
        • Sloan D.M.
        • Keane T.M.
        • et al.
        Stress- and PTSD-associated obesity and metabolic dysfunction: a growing problem requiring further research and novel treatments.
        Metabolism. 2014; 63: 1463-1468
        • Martin A.A.
        • Davidson T.L.
        Human cognitive function and the obesogenic environment.
        Physiol Behav. 2014; 136: 185-193
        • Parent M.B.
        • Darling J.N.
        • Henderson Y.O.
        Remembering to eat: hippocampal regulation of meal onset.
        Am J Physiol Regul Integr Comp Physiol. 2014; 306: R701-R713
        • Doolan K.J.
        • Breslin G.
        • Hanna D.
        • et al.
        Attentional bias to food-related visual cues: is there a role in obesity?.
        Proc Nutr Soc. 2015; 74: 37-45
        • Leland D.S.
        • Pineda J.A.
        Effects of food-related stimuli on visual spatial attention in fasting and nonfasting normal subjects: Behavior and electrophysiology.
        Clin Neurophysiol. 2006; 117: 67-84
        • Placanica J.L.
        • Faunce G.J.
        • Soames Job R.F.
        The effect of fasting on attentional biases for food and body shape/weight words in high and low Eating Disorder Inventory scorers.
        Int J Eat Disord. 2002; 32: 79-90
        • Ahern A.L.
        • Field M.
        • Yokum S.
        • et al.
        Relation of dietary restraint scores to cognitive biases and reward sensitivity.
        Appetite. 2010; 55: 61-68
        • Brignell C.
        • Griffiths T.
        • Bradley B.P.
        • et al.
        Attentional and approach biases for pictorial food cues. Influence of external eating.
        Appetite. 2009; 52: 299-306
        • Van Strien T.
        • Schippers G.M.
        • Cox W.M.
        On the relationship between emotional and external eating behavior.
        Addict Behav. 1995; 20: 585-594
        • Fuhrer D.
        • Zysset S.
        • Stumvoll M.
        Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study.
        Obesity (Silver Spring). 2008; 16: 945-950
        • Schur E.A.
        • Kleinhans N.M.
        • Goldberg J.
        • et al.
        Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus.
        Int J Obes. 2009; 33: 653-661
        • Aron A.R.
        From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses.
        Biol Psychiatry. 2011; 69: e55-68
        • Anzman-Frasca S.
        • Francis L.A.
        • Birch L.L.
        Inhibitory control is associated with psychosocial, cognitive, and weight outcomes in a longitudinal sample of girls.
        Transl Issues Psychol Sci. 2015; 1: 203-216
        • Blanco-Gomez A.
        • Ferre N.
        • Luque V.
        • et al.
        Being overweight or obese is associated with inhibition control in children from six to ten years of age.
        Acta Paediatr. 2015; 104: 619-625
        • Chamberlain S.R.
        • Derbyshire K.L.
        • Leppink E.
        • et al.
        Obesity and dissociable forms of impulsivity in young adults.
        CNS Spectr. 2015; 20: 500-507
        • He Q.
        • Xiao L.
        • Xue G.
        • et al.
        Poor ability to resist tempting calorie rich food is linked to altered balance between neural systems involved in urge and self-control.
        Nutr J. 2014; 13: 92
        • Khan N.A.
        • Raine L.B.
        • Drollette E.S.
        • et al.
        The relationship between total water intake and cognitive control among prepubertal children.
        Ann Nutr Metab. 2015; 66: 38-41
        • Kullmann S.
        • Heni M.
        • Veit R.
        • et al.
        Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults.
        Diabetes Care. 2015; 38: 1044-1050
        • Levitan R.D.
        • Rivera J.
        • Silveira P.P.
        • et al.
        Gender differences in the association between stop-signal reaction times, body mass indices and/or spontaneous food intake in pre-school children: an early model of compromised inhibitory control and obesity.
        Int J Obes (Lond). 2015; 39: 614-619
        • Reyes S.
        • Peirano P.
        • Peigneux P.
        • et al.
        Inhibitory control in otherwise healthy overweight 10-year-old children.
        Int J Obes (Lond). 2015; 39: 1230-1235
        • Svaldi J.
        • Naumann E.
        • Trentowska M.
        • et al.
        General and food-specific inhibitory deficits in binge eating disorder.
        Int J Eat Disord. 2014; 47: 534-542
        • Tuulari J.J.
        • Karlsson H.K.
        • Hirvonen J.
        • et al.
        Neural circuits for cognitive appetite control in healthy and obese individuals: an fMRI study.
        PLoS One. 2015; 10: e0116640
        • Wirt T.
        • Hundsdorfer V.
        • Schreiber A.
        • et al.
        Associations between inhibitory control and body weight in German primary school children.
        Eat Behav. 2014; 15: 9-12
        • Wirt T.
        • Schreiber A.
        • Kesztyus D.
        • et al.
        Early life cognitive abilities and body weight: cross-sectional study of the association of inhibitory control, cognitive flexibility, and sustained attention with BMI percentiles in primary school children.
        J Obes. 2015; 2015: 534651
        • Hendrick O.M.
        • Luo X.
        • Zhang S.
        • et al.
        Saliency processing and obesity: a preliminary imaging study of the stop signal task.
        Obesity (Silver Spring). 2012; 20: 1796-1802
        • Nederkoorn C.
        • Jansen E.
        • Mulkens S.
        • et al.
        Impulsivity predicts treatment outcome in obese children.
        Behav Res Ther. 2007; 45: 1071-1075
        • Chapman C.D.
        • Benedict C.
        • Brooks S.J.
        • et al.
        Lifestyle determinants of the drive to eat: a meta-analysis.
        Am J Clin Nutr. 2012; 96: 492-497
        • Volkow N.D.
        • Wang G.J.
        • Fowler J.S.
        • et al.
        Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology.
        Philos Trans R Soc Lond B Biol Sci. 2008; 363: 3191-3200
        • Hotamisligil G.S.
        • Arner P.
        • Caro J.F.
        • et al.
        Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
        J Clin Invest. 1995; 95: 2409-2415
        • Lumeng C.N.
        • Saltiel A.R.
        Inflammatory links between obesity and metabolic disease.
        J Clin Invest. 2011; 121: 2111-2117
        • Brestoff J.R.
        • Artis D.
        Immune regulation of metabolic homeostasis in health and disease.
        Cell. 2015; 161: 146-160
        • De Souza C.T.
        • Araujo E.P.
        • Bordin S.
        • et al.
        Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus.
        Endocrinology. 2005; 146: 4192-4199
        • Grayson B.E.
        • Levasseur P.R.
        • Williams S.M.
        • et al.
        Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet.
        Endocrinology. 2010; 151: 1622-1632
        • Thaler J.P.
        • Yi C.X.
        • Schur E.A.
        • et al.
        Obesity is associated with hypothalamic injury in rodents and humans.
        J Clin Invest. 2012; 122: 153-162
        • Valdearcos M.
        • Robblee M.M.
        • Benjamin D.I.
        • et al.
        Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function.
        Cell Rep. 2014; 9: 2124-2138
        • Horvath T.L.
        • Sarman B.
        • Garcia-Caceres C.
        • et al.
        Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity.
        Proc Natl Acad Sci U S A. 2010; 107: 14875-14880
        • Phillips C.M.
        • Dillon C.
        • Harrington J.M.
        • et al.
        Defining metabolically healthy obesity: role of dietary and lifestyle factors.
        PLoS One. 2013; 8: e76188
        • Wildman R.P.
        • Muntner P.
        • Reynolds K.
        • et al.
        The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
        Arch Intern Med. 2008; 168: 1617-1624
        • Van Gaal L.F.
        • Mertens I.L.
        • De Block C.E.
        Mechanisms linking obesity with cardiovascular disease.
        Nature. 2006; 444: 875-880
        • Mokdad A.H.
        • Ford E.S.
        • Bowman B.A.
        • et al.
        Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
        JAMA. 2003; 289: 76-79
        • Achilike I.
        • Hazuda H.P.
        • Fowler S.P.
        • et al.
        Predicting the development of the metabolically healthy obese phenotype.
        Int J Obes (Lond). 2015; 39: 228-234
        • Velho S.
        • Paccaud F.
        • Waeber G.
        • et al.
        Metabolically healthy obesity: different prevalences using different criteria.
        Eur J Clin Nutr. 2010; 64: 1043-1051
        • Lee K.
        Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors.
        Asia Pac J Clin Nutr. 2009; 18: 280-284
        • Bell J.A.
        • Hamer M.
        • Sabia S.
        • et al.
        The natural course of healthy obesity over 20 years.
        J Am Coll Cardiol. 2015; 65: 101-102
        • Appleton S.L.
        • Seaborn C.J.
        • Visvanathan R.
        • et al.
        Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.
        Diabetes Care. 2013; 36: 2388-2394
        • Kabat G.C.
        • Wu W.Y.
        • Bea J.W.
        • et al.
        Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.
        Int J Obes (Lond). 2017; 41: 170-177
        • Sahakyan K.R.
        • Somers V.K.
        • Rodriguez-Escudero J.P.
        • et al.
        Normal-weight central obesity: implications for total and cardiovascular mortality.
        Ann Intern Med. 2015; 163: 827-835
        • Canoy D.
        • Boekholdt S.M.
        • Wareham N.
        • et al.
        Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study.
        Circulation. 2007; 116: 2933-2943
        • Song Y.M.
        • Sung J.
        • Davey Smith G.
        • et al.
        Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men.
        Stroke. 2004; 35: 831-836
        • Zhang M.
        • Hu T.
        • Zhang S.
        • et al.
        Associations of different adipose tissue depots with insulin resistance: a systematic review and meta-analysis of observational studies.
        Sci Rep. 2015; 5: 18495
        • Kahn S.E.
        • Hull R.L.
        • Utzschneider K.M.
        Mechanisms linking obesity to insulin resistance and type 2 diabetes.
        Nature. 2006; 444: 840-846
        • Shulman G.I.
        Cellular mechanisms of insulin resistance.
        J Clin Invest. 2000; 106: 171-176
        • Osborn O.
        • Olefsky J.M.
        The cellular and signaling networks linking the immune system and metabolism in disease.
        Nat Med. 2012; 18: 363-374
        • Kadowaki T.
        • Yamauchi T.
        • Kubota N.
        • et al.
        Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
        J Clin Invest. 2006; 116: 1784-1792
        • Scherer P.E.
        Adipose tissue: from lipid storage compartment to endocrine organ.
        Diabetes. 2006; 55: 1537-1545
        • Kahn S.E.
        • Prigeon R.L.
        • McCulloch D.K.
        • et al.
        Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.
        Diabetes. 1993; 42: 1663-1672
        • Hara K.
        • Shojima N.
        • Hosoe J.
        • et al.
        Genetic architecture of type 2 diabetes.
        Biochem Biophys Res Commun. 2014; 452: 213-220
        • Kahn S.E.
        Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.
        J Clin Endocrinol Metab. 2001; 86: 4047-4058
        • Butler A.E.
        • Janson J.
        • Bonner-Weir S.
        • et al.
        Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
        Diabetes. 2003; 52: 102-110
        • Vazquez G.
        • Duval S.
        • Jacobs Jr., D.R.
        • et al.
        Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis.
        Epidemiol Rev. 2007; 29: 115-128
        • Bell J.A.
        • Kivimaki M.
        • Hamer M.
        Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies.
        Obes Rev. 2014; 15: 504-515
        • Power C.
        • Thomas C.
        Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort.
        Diabetes Care. 2011; 34: 1986-1991
        • Chan D.C.
        • Barrett H.P.
        • Watts G.F.
        Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.
        Am J Cardiovasc Drugs. 2004; 4: 227-246
        • Brown C.D.
        • Higgins M.
        • Donato K.A.
        • et al.
        Body mass index and the prevalence of hypertension and dyslipidemia.
        Obes Res. 2000; 8: 605-619
        • Susic D.
        • Varagic J.
        Obesity: a perspective from hypertension.
        Med Clin North Am. 2017; 101: 139-157
        • Messerli F.H.
        • Christie B.
        • DeCarvalho J.G.
        • et al.
        Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.
        Arch Intern Med. 1981; 141: 81-85
        • Amann K.
        • Benz K.
        Structural renal changes in obesity and diabetes.
        Semin Nephrol. 2013; 33: 23-33
        • Hall M.E.
        • do Carmo J.M.
        • da Silva A.A.
        • et al.
        Obesity, hypertension, and chronic kidney disease.
        Int J Nephrol Renovasc Dis. 2014; 7: 75-88
        • Kurukulasuriya L.R.
        • Stas S.
        • Lastra G.
        • et al.
        Hypertension in obesity.
        Med Clin North Am. 2011; 95: 903-917
        • Furukawa S.
        • Fujita T.
        • Shimabukuro M.
        • et al.
        Increased oxidative stress in obesity and its impact on metabolic syndrome.
        J Clin Invest. 2004; 114: 1752-1761
        • Kim J.A.
        • Montagnani M.
        • Koh K.K.
        • et al.
        Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.
        Circulation. 2006; 113: 1888-1904
        • Sprague A.H.
        • Khalil R.A.
        Inflammatory cytokines in vascular dysfunction and vascular disease.
        Biochem Pharmacol. 2009; 78: 539-552
        • Kenchaiah S.
        • Evans J.C.
        • Levy D.
        • et al.
        Obesity and the risk of heart failure.
        N Engl J Med. 2002; 347: 305-313
        • Lu Y.
        • Hajifathalian K.
        • Ezzati M.
        • et al.
        Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants.
        Lancet. 2014; 383: 970-983
        • Wormser D.
        • Kaptoge S.
        • Di Angelantonio E.
        • et al.
        Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
        Lancet. 2011; 377: 1085-1095
        • Fan J.
        • Song Y.
        • Chen Y.
        • et al.
        Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies.
        Int J Cardiol. 2013; 168: 4761-4768
        • Juonala M.
        • Magnussen C.G.
        • Berenson G.S.
        • et al.
        Childhood adiposity, adult adiposity, and cardiovascular risk factors.
        N Engl J Med. 2011; 365: 1876-1885
        • Gambineri A.
        • Pelusi C.
        • Vicennati V.
        • et al.
        Obesity and the polycystic ovary syndrome.
        Int J Obes Relat Metab Disord. 2002; 26: 883-896
        • Rojas J.
        • Chavez M.
        • Olivar L.
        • et al.
        Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.
        Int J Reprod Med. 2014; 2014: 719050
        • Baldani D.P.
        • Skrgatic L.
        • Ougouag R.
        Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women.
        Int J Endocrinol. 2015; 2015: 786362
        • Blank S.K.
        • McCartney C.R.
        • Chhabra S.
        • et al.
        Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls–implications for regulation of pubertal maturation.
        J Clin Endocrinol Metab. 2009; 94: 2360-2366
        • Marshall J.C.
        • Dunaif A.
        Should all women with PCOS be treated for insulin resistance?.
        Fertil Steril. 2012; 97: 18-22
        • Tock L.
        • Carneiro G.
        • Pereira A.Z.
        • et al.
        Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.
        Int J Endocrinol. 2014; 2014: 620605
        • Ibanez L.
        • Potau N.
        • Virdis R.
        • et al.
        Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.
        J Clin Endocrinol Metab. 1993; 76: 1599-1603
        • l'Allemand D.
        • Schmidt S.
        • Rousson V.
        • et al.
        Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche.
        Eur J Endocrinol. 2002; 146: 537-543
        • Baptiste C.G.
        • Battista M.C.
        • Trottier A.
        • et al.
        Insulin and hyperandrogenism in women with polycystic ovary syndrome.
        J Steroid Biochem Mol Biol. 2010; 122: 42-52
        • Norman R.J.
        • Noakes M.
        • Wu R.
        • et al.
        Improving reproductive performance in overweight/obese women with effective weight management.
        Hum Reprod Update. 2004; 10: 267-280
        • Kiddy D.S.
        • Hamilton-Fairley D.
        • Bush A.
        • et al.
        Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
        Clin Endocrinol. 1992; 36: 105-111
        • Yildiz B.O.
        • Bolour S.
        • Woods K.
        • et al.
        Visually scoring hirsutism.
        Hum Reprod Update. 2010; 16: 51-64
        • Sam S.
        Obesity and polycystic ovary syndrome.
        Obes Manag. 2007; 3: 69-73
        • Lee Y.H.
        • Johan A.
        • Wong K.K.
        • et al.
        Prevalence and risk factors for obstructive sleep apnea in a multiethnic population of patients presenting for bariatric surgery in Singapore.
        Sleep Med. 2009; 10: 226-232
        • Kositanurit W.
        • Muntham D.
        • Udomsawaengsup S.
        • et al.
        Prevalence and associated factors of obstructive sleep apnea in morbidly obese patients undergoing bariatric surgery.
        Sleep Breath. 2017; ([Epub ahead of print])
        • Jean-Louis G.
        • Zizi F.
        • Clark L.T.
        • et al.
        Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components.
        J Clin Sleep Med. 2008; 4: 261-272
        • Romero-Corral A.
        • Caples S.M.
        • Lopez-Jimenez F.
        • et al.
        Interactions between obesity and obstructive sleep apnea: implications for treatment.
        Chest. 2010; 137: 711-719
        • Hurt R.T.
        • Kulisek C.
        • Buchanan L.A.
        • et al.
        The obesity epidemic: challenges, health initiatives, and implications for gastroenterologists.
        Gastroenterol Hepatol. 2010; 6: 780-792
        • Zammit C.
        • Liddicoat H.
        • Moonsie I.
        • et al.
        Obesity and respiratory diseases.
        Int J Gen Med. 2010; 3: 335-343
        • Babu A.R.
        • Herdegen J.
        • Fogelfeld L.
        • et al.
        Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea.
        Arch Intern Med. 2005; 165: 447-452
        • Strohl K.P.
        • Butler J.P.
        • Malhotra A.
        Mechanical properties of the upper airway.
        Compr Physiol. 2012; 2: 1853-1872
        • Dempsey J.A.
        • Veasey S.C.
        • Morgan B.J.
        • et al.
        Pathophysiology of sleep apnea.
        Physiol Rev. 2010; 90: 47-112
        • Schwartz A.R.
        • Smith P.L.
        • Oliven A.
        Electrical stimulation of the hypoglossal nerve: a potential therapy.
        J Appl Physiol (1985). 2014; 116: 337-344
        • Schwartz A.R.
        • Patil S.P.
        • Laffan A.M.
        • et al.
        Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.
        Proc Am Thorac Soc. 2008; 5: 185-192
        • Shigeta Y.
        • Ogawa T.
        • Tomoko I.
        • et al.
        Soft palate length and upper airway relationship in OSA and non-OSA subjects.
        Sleep Breath. 2010; 14: 353-358
        • Zancanella E.
        • Haddad F.M.
        • Oliveira L.A.
        • et al.
        Obstructive sleep apnea and primary snoring: diagnosis.
        Braz J Otorhinolaryngology. 2014; 80: S1-S16
        • Daulatzai M.A.
        Role of sensory stimulation in amelioration of obstructive sleep apnea.
        Sleep Disord. 2011; 2011: 596879
        • Tuomilehto H.P.
        • Seppa J.M.
        • Partinen M.M.
        • et al.
        Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.
        Am J Respir Crit Care Med. 2009; 179: 320-327
        • Dobbins M.
        • Decorby K.
        • Choi B.C.
        The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011.
        ISRN Prev Med. 2013; 2013: 680536
        • Vainio H.
        • Kaaks R.
        • Bianchini F.
        Weight control and physical activity in cancer prevention: international evaluation of the evidence.
        Eur J Cancer Prev. 2002; 11: S94-S100
        • Calle E.E.
        • Rodriguez C.
        • Walker-Thurmond K.
        • et al.
        Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
        N Engl J Med. 2003; 348: 1625-1638
        • Berrington de Gonzalez A.
        • Hartge P.
        • Cerhan J.R.
        • et al.
        Body-mass index and mortality among 1.46 million white adults.
        N Engl J Med. 2010; 363: 2211-2219
        • Sjostrom L.
        • Gummesson A.
        • Sjostrom C.D.
        • et al.
        Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial.
        Lancet Oncol. 2009; 10: 653-662
        • Park J.
        • Euhus D.M.
        • Scherer P.E.
        Paracrine and endocrine effects of adipose tissue on cancer development and progression.
        Endocr Rev. 2011; 32: 550-570
        • Ziemke F.
        • Mantzoros C.S.
        Adiponectin in insulin resistance: lessons from translational research.
        Am J Clin Nutr. 2010; 91: 258S-261S
        • Kelesidis I.
        • Kelesidis T.
        • Mantzoros C.S.
        Adiponectin and cancer: a systematic review.
        Br J Cancer. 2006; 94: 1221-1225
        • Dalamaga M.
        • Diakopoulos K.N.
        • Mantzoros C.S.
        The role of adiponectin in cancer: a review of current evidence.
        Endocr Rev. 2012; 33: 547-594
        • Jain S.S.
        • Bird R.P.
        Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats.
        Int J Cancer. 2010; 127: 2042-2050
        • Khandekar M.J.
        • Cohen P.
        • Spiegelman B.M.
        Molecular mechanisms of cancer development in obesity.
        Nat Rev Cancer. 2011; 11: 886-895
        • Park E.J.
        • Lee J.H.
        • Yu G.Y.
        • et al.
        Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.
        Cell. 2010; 140: 197-208